Interestingly, blocking VISTA in tumor cells extended mice survival that was inoculated with ovarian cancer cells overexpressing VISTA, although combined therapy using anti-PD-1 and anti-VISTA did not further improve mice survival compared to anti-VISTA treatment alone38. The gene discussed is VSIR; the disease is ovarian cancer.